Generic name: TETRAFERRIC TRICITRATE DECAHYDRATE 210mg
Dosage form: tablet, coated
Medically reviewed on November 13, 2017.
2.1 Dosage for Hyperphosphatemia in Chronic Kidney Disease on Dialysis
The recommended starting dose is 2 tablets orally 3 times per day with meals. Monitor serum phosphorus levels and titrate the Auryxia dose in decrements or increments of 1 to 2 tablets per day as needed to maintain serum phosphorus at target levels, up to a maximum dose of 12 tablets daily. Dose can be titrated at 1-week or longer intervals.
In a clinical trial, patients required an average of 8 to 9 tablets a day to control serum phosphorus levels.
2.2 Dosage for Iron Deficiency Anemia in Chronic Kidney Disease Not on Dialysis
The recommended starting dose is 1 tablet orally 3 times per day with meals. Titrate the dose of Auryxia as needed to achieve and maintain hemoglobin at target levels, up to a maximum dose of 12 tablets daily.
In a clinical trial in patients with chronic kidney disease not on dialysis (CKD-NDD), patients required an average of 5 tablets per day to increase hemoglobin levels.
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
More about Auryxia (ferric citrate)
- Auryxia Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 2 Reviews
- Drug class: phosphate binders